Ketley N J, Mills M J, Traub N E, Brown A A
Department of Haematology, Southend Hospital, Essex.
Clin Lab Haematol. 1992;14(3):179-88. doi: 10.1111/j.1365-2257.1992.tb00363.x.
Review of splenectomies carried out for haematological disease over a ten-year period, at a district hospital, shows that the indications for splenectomy have changed substantially over this time. Fewer patients with idiopathic thrombocytopenic purpura now require splenectomy, however its role in the management of lymphoproliferative disorders has expanded. Splenectomy remains an important therapeutic option for a range of haematological disorders: this series shows it to be a safe and effective operation in selected patients, although it is not without both short and long-term sequelae.
对一家地区医院在十年间因血液系统疾病进行脾切除术的回顾显示，在此期间脾切除术的指征发生了显著变化。现在，患有特发性血小板减少性紫癜的患者需要脾切除术的人数减少了，然而其在淋巴增生性疾病管理中的作用有所扩大。脾切除术仍然是一系列血液系统疾病的重要治疗选择：该系列研究表明，对于选定的患者而言，这是一种安全有效的手术，尽管它并非没有短期和长期后遗症。
